76 results

The Sharp Building at Hogan Place, Dublin 2

Perrigo, the leading global healthcare supplier, is to rent an impressive new €20 million headquarters office building developed by the McGarrell Rei(...)

Tysabri, the multiple sclerosis drug developed by Elan and subsequently acquired by Perrigo in 2013, has now been sold on to Royalty Pharma for up to €2.7 billion

Irish consumer healthcare and generic drug group Perrigo said has agreed to sell the royalty stream from its multiple sclerosis drug Tysabri to anothe(...)

Activist investor Starboard Value targeted the Dublin-based drugmaker Perrigo last year and urged it to explore a sale of its prescription business. Photograph: Getty Images

Dublin-based consumer health and generics group Perrigo is shaking up its board and replacing half of its directors with members tied to an activist i(...)

Tysabri, the multiple sclerosis drug developed by Elan, may be sold again as Perrigo examines options.

Consumer health and generics group Perrigo is reviewing strategic options for royalty rights from sales of its multiple sclerosis drug Tysabri after r(...)

 Treasury Building on Lower Grand Canal Street, Dublin: located in an area with an influx of international companies such as Google, Twitter, Facebook, Accenture and Stripe.  Photograph: Eric Luke

An unusual investment opportunity involving one of Dublin’s best-known office buildings is to be unveiled later this week by agents CBRE when they off(...)

Perrigo said the deal would further strengthen its US distribution business

Perrigo, the Irish domiciled over-the-counter drug company, has acquired US healthcare distributor Geiss, Destin & Dunn for an undisclosed sum. Th(...)

A truck is parked at the loading dock at the Perrigo  facility in Allegan, Michigan. Photograph: Adam Bird/Bloomberg

Perrigo, the Irish domiciled over-the-counter drug specialist, slashed its full-year earnings forecast for the second time, citing pricing pressure in(...)

 Robert Coury, executive chairman of  Mylan pharmacutical company with Taoiseach Enda Kenny in 2012 announcing more than 500 jobs between plants at Baldoyle in Dublin and Galway.Photograph: Alan Betson / The Irish Times

Drugmaker Mylan posted a 17 per cent rise in quarterly revenue, helped by higher generic drug sales, and stood by its full-year revenue and adjusted p(...)

Joe Papa (above) has been tapped by rival Valeant to fill the shoes vacated by Canadian Mike Pearson. Photograph: Brenda Fitzsimons / The Irish Times

Perrigo, the over-the-counter drugs specialist that moved its domicile to Ireland when it took over the rump of Elan’s business in 2013, is losing its(...)

Drugmaker Perrigo is to replace chief executive  Joseph Papa with president John Hendrickson (pictured) the company said on Monday. Papa will join rival  Valeant Pharmaceuticals International Inc. as CEO. (Phootgraph: Amir Cohen/Reuters)

Valeant Pharmaceuticals named Joseph Papa as its chief executive on Monday, the day after he resigned from the top spot at drugmaker Perrigo. The m(...)

  • « First
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next
  • Last »